| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.9 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.049 | 0.9 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |